Preformulation studies on grewia gum as a formulation excipient

被引:0
|
作者
Elijah I. Nep
Barbara R. Conway
机构
[1] Aston University,Life and Health Sciences
[2] University of Jos,Department of Pharmaceutics and Pharmaceutical Technology
[3] University of Huddersfield,Pharmacy, School of Applied Sciences
关键词
Cimetidine; Ibuprofen; Grewia gum; Excipients; DSC; FT-IR;
D O I
暂无
中图分类号
学科分类号
摘要
Grewia gum is a naturally occurring polysaccharide which has potential as a pharmaceutical excipient. Differential scanning calorimetry and Fourier transform infrared (FT-IR) spectroscopy techniques were used to examine the thermal and molecular behaviours, respectively, of mixtures of grewia gum with cimetidine, ibuprofen or standard excipients, to assess potential interactions. No disappearance or broadening of the melting endotherm was seen with cimetidine or ibuprofen. Similarly, there was no interaction between grewia gum and the standard excipients tested. The results obtained using thermal analyses were supported by FT-IR analysis of the material mixtures. Grewia gum is an inert natural polymer which can be used alone or in combination with other excipients in the formulation of pharmaceutical dosage forms.
引用
收藏
页码:197 / 205
页数:8
相关论文
共 50 条
  • [1] Preformulation studies on grewia gum as a formulation excipient
    Nep, Elijah I.
    Conway, Barbara R.
    [J]. JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 2012, 108 (01) : 197 - 205
  • [2] Preformulation of a liquid dosage formulation of captopril for pediatric use: drug-excipient compatibility and stability studies
    Goes, Janaina da Silva
    Freire, Fatima Duarte
    Accioly de Lima e Moura, Tulio Flavio
    Soares Aragao, Cicero Flavio
    Raffin, Fernanda Nervo
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 55
  • [3] Effect of Grewia Gum as a Suspending Agent on Ibuprofen Pediatric Formulation
    Ogaji, Ikoni Joshua
    Hoag, Stephen W.
    [J]. AAPS PHARMSCITECH, 2011, 12 (02): : 507 - 513
  • [4] Effect of Grewia Gum as a Suspending Agent on Ibuprofen Pediatric Formulation
    Ikoni Joshua Ogaji
    Stephen W. Hoag
    [J]. AAPS PharmSciTech, 2011, 12 : 507 - 513
  • [5] Evaluation of Caralluma attenuata Starch as an Alternative Tablet Excipient to Potato and Maize Starch: Assessment by Preformulation and Formulation Studies
    Venkatesh, Sama
    Babashankar, G.
    Latha, K.
    Reddy, Madhava B.
    Mullangi, Ramesh
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL EDUCATION AND RESEARCH, 2011, 45 (03) : 218 - 224
  • [6] Instrumental Analysis of Potential Lovastatin - excipient Interactions in Preformulation Studies
    Ledeti, Ionut
    Vlase, Gabriela
    Vlase, Titus
    Ciucanu, Ionel
    Olariu, Tudor
    Todea, Anamaria
    Fulias, Adriana
    Suta, Lenuta-Maria
    [J]. REVISTA DE CHIMIE, 2015, 66 (06): : 879 - 882
  • [7] Applications of XRD in Preformulation and Formulation Studies
    Suryanarayanan, R.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2014, 70 : C1562 - C1562
  • [8] DSC Screening of Potential Prochlorperazine-Excipient Interactions in Preformulation Studies
    M. E. Brown
    E. M. Antunes
    B. D. Glass
    M. Lebete
    R. B. Walker
    [J]. Journal of Thermal Analysis and Calorimetry, 1999, 56 : 1317 - 1322
  • [9] DSC screening of potential prochlorperazine-excipient interactions in preformulation studies
    Brown, ME
    Antunes, EM
    Glass, BD
    Lebete, M
    Walker, RB
    [J]. JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY, 1999, 56 (03): : 1317 - 1322
  • [10] Using Different Experimental Designs in Drug-Excipient Compatibility Studies During the Preformulation Development of a Stable Solid Dosage Formulation
    Bohanec, Simona
    Peterka, Tanja Rozman
    Blazic, Petra
    Jurecic, Rok
    Grmas, Jernej
    Krivec, Aleksandra
    Zakrajsek, Jure
    [J]. ACTA CHIMICA SLOVENICA, 2010, 57 (04) : 895 - 903